ReviewFrontiers in immunology2021
Modulation of Intestinal ILC3 for the Treatment of Type 1 Diabetes.
Ivana Stojanović et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this paperpooled itcites it
ReviewFrontiers in immunology2021
Ivana Stojanović et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.